Immunity against Neisseria meningitidis Serogroup C in the Dutch Population before and after Introduction of the Meningococcal C Conjugate Vaccine

BACKGROUND: In 2002 a Meningococcal serogroup C (MenC) conjugate vaccine, with tetanus toxoid as carrier protein, was introduced in the Netherlands as a single-dose at 14 months of age. A catch-up campaign was performed targeting all individuals aged 14 months to 18 years. We determined the MenC-spe...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: de Voer, Richarda M., Mollema, Liesbeth, Schepp, Rutger M., de Greeff, Sabine C., van Gageldonk, Pieter G. M., de Melker, Hester E., Sanders, Elisabeth A. M., Berbers, Guy A. M., van der Klis, Fiona R. M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2010
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921331/
https://ncbi.nlm.nih.gov/pubmed/20730091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0012144
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia